HENNIGSDORF, Germany, March 6 /PRNewswire/ -- Recently the State of Brandenburg, and the EU, awarded two grants, valued at about 850,000 euro, to Alcat Europe, GmbH, covering marketing and employee costs during early years of operation.
Alcat Europe, a laboratory company located in the BioTech Park in Hennigsdorf (Berlin) engages in testing client blood samples for food and chemical sensitivities through the Alcat test method. The grants demonstrate the confidence the Brandenburg government has in the company's innovative technology, and the company's ability to fulfill the need for a reliable test to identify foods and chemicals associated with numerous health disorders.
"We are pleased that the EU and the State of Brandenburg recognize the importance of food intolerance for the health of the German public," stated Anja Noa Koch, Prokura of Alcat Europe.
Roger Deutsch, CEO of Alcat Europe and the parent US company, CSS, states, "We are grateful for this recognition as well as the substantial resource of highly qualified scientific institutions and personnel in the area to support our growth."
Alcat Europe, GmbH is a wholly owned subsidiary of Cell Science Systems, Ltd., Corp., (CSS) of Deerfield Beach, Florida (USA). CSS, CLIA licensed and registered with the US FDA as a device manufacturer, is a fully integrated medical and health technology company on the cutting edge of research, diagnosis and management of food and chemical sensitivities. CSS operates a lab and manufactures the hardware, software and reagent systems used in the performance of the Alcat test for world wide distribution.
The Alcat test (http://www.alcat.com) has been awarded three international
patents. It is an accurate blood test for detecting delayed type reactions
to foods, chemicals, and other substances, that manifest inflammatory
conditions, such as; migraine, arthritis, skin and respiratory disorder
Copyright©2008 PR Newswire.
All rights reserved